kConFab Letter of Intent Submissions
DateInvestigatorsAffiliationProject Title
November 2018
Full project
Kate Nathanson, Susan Domchek and Georgia Chenevix-Trench University of Pennsylvania, USA and QIMR Brisbane Immunogenicity in BRCA1/2 mutation carriers
October 2018
Full application
Kara Maxwell et al University of Pennsylvania, USA Genotype-phenotype study of breast tumors from patients with Li-Fraumeni Syndrome
January 2019
Full project
Martha Hickey, Kelly Phillips and Karla Hutt The University of Melbourne, Monash University and The Peter MacCallum Cancer Centre, Melbourne Do BRCA1 and BRCA2 gene mutation carriers have decreased ovarian reserve?
January 2019
Full application
Robert G Bristow, Gail Risbridger et al CRUK Manchester Institute, United Kingdom and Monash University MBDI Institute & Peter MacCallum Cancer Centre, Melbourne Models of germline BRCA2-mutant prostate cancer
September 2019
Full project
James Fackenthal et al. Department of Biological Sciences, Benedictine University, USA RNAseq assessment of global splicing disruption as an indicator of BRCA1/2 pathogenic variant status.

A pilot or full application must be made within 6 months of submitting the letter of intent. If more than six months has elapsed, a new letter of intent must be submitted prior to the full application.